IN187998B - - Google Patents

Info

Publication number
IN187998B
IN187998B IN337DE1998A IN187998B IN 187998 B IN187998 B IN 187998B IN 337DE1998 A IN337DE1998 A IN 337DE1998A IN 187998 B IN187998 B IN 187998B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Patrice Debregeas
Gerard Leduc
Pascal Oury
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Publication of IN187998B publication Critical patent/IN187998B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
IN337DE1998 1997-02-11 1998-02-10 IN187998B (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9701545A FR2759293B1 (fr) 1997-02-11 1997-02-11 Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie

Publications (1)

Publication Number Publication Date
IN187998B true IN187998B (xx) 2002-08-03

Family

ID=9503556

Family Applications (1)

Application Number Title Priority Date Filing Date
IN337DE1998 IN187998B (xx) 1997-02-11 1998-02-10

Country Status (24)

Country Link
US (2) US6458389B1 (xx)
EP (1) EP0971702B1 (xx)
JP (1) JP4549445B2 (xx)
KR (1) KR100471672B1 (xx)
AR (1) AR011133A1 (xx)
AT (1) ATE255409T1 (xx)
BG (1) BG64247B1 (xx)
BR (1) BR9807319A (xx)
CA (1) CA2282082C (xx)
DE (1) DE69820239T2 (xx)
DK (1) DK0971702T3 (xx)
EA (1) EA001760B1 (xx)
ES (1) ES2210726T3 (xx)
FR (1) FR2759293B1 (xx)
HU (1) HU225425B1 (xx)
IL (1) IL131326A (xx)
IN (1) IN187998B (xx)
NO (1) NO323230B1 (xx)
NZ (1) NZ337216A (xx)
PL (1) PL191631B1 (xx)
PT (1) PT971702E (xx)
TW (1) TW561055B (xx)
WO (1) WO1998034599A1 (xx)
ZA (1) ZA981123B (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050096304A1 (en) * 1998-09-08 2005-05-05 David White Method of treating cancer using dithiocarbamate derivatives
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
BR0010649A (pt) * 1999-05-17 2002-02-19 D B F Grãnulos que contêm pelo menos uma substância vegetal e processo de preparação dos mesmos
WO2005034923A1 (en) * 2003-10-10 2005-04-21 Ethypharm Sustained-release microgranules containing gingko biloba extract and the process for manufacturing these
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
CA2588400A1 (en) * 2004-11-18 2006-05-26 Bristol-Myers Squibb Company Enteric coated bead comprising ixabepilone, and preparation thereof
US20080069901A1 (en) * 2004-12-10 2008-03-20 Tmrc Co. , Ltd. Therapeutic Agent for Metastatic Cancer and Cancer Metastasis Inhibitor
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
FR2918566B1 (fr) * 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
CA2699227C (en) * 2007-09-21 2014-12-02 Evonik Roehm Gmbh Ph-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol
JP5204846B2 (ja) * 2007-09-21 2013-06-05 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング エタノールの影響に対して耐性を有する非オピオイド薬のｐＨ依存性制御放出医薬組成物
WO2009086940A1 (en) * 2008-01-10 2009-07-16 Evonik Röhm Gmbh Coated pharmaceutical or nutraceutical preparation with enhanced active substance release in the colon
KR20100103565A (ko) * 2008-01-10 2010-09-27 에보니크 룀 게엠베하 촉진되고 조절된 활성 물질 방출을 갖는 코팅된 제약학적 또는 건강기능성 제제
DK177529B1 (en) * 2009-10-23 2013-09-08 Bio Bedst Aps Liposomes with improved storage stability
CA2688202C (en) * 2009-12-11 2012-11-13 Bj Services Company Viscoelastic fluids containing hydroxyethyl cellulose
EP2371356B1 (en) * 2010-03-12 2012-12-19 Phoeme GmbH Multi-particle pharmaceutical formulation for colon absorption
US8070047B1 (en) * 2010-12-02 2011-12-06 Rohm And Haas Electronic Materials Llc Flux composition and method of soldering
CN105025904A (zh) 2012-09-04 2015-11-04 埃莱森制药有限责任公司 用顺铂脂质复合物预防癌症的肺部复发
AU2015311674B2 (en) * 2014-09-05 2018-03-08 Lupin Inc. Secnidazole for use in the treatment of bacterial vaginosis
WO2016169042A1 (en) * 2015-04-24 2016-10-27 Genedia Biotech Co. Ltd. Combination therapies for bladder cancer
CA2988082C (en) * 2015-06-01 2020-09-29 Symbiomix Therapeutics, Llc Novel nitroimidazole formulations and uses thereof
EP3307239B1 (en) 2015-06-12 2020-09-16 Vaxart, Inc. Formulations for small intestinal delivery of rsv and norovirus antigens
JP6590436B1 (ja) * 2018-04-24 2019-10-16 塩野義製薬株式会社 安定性に優れた固形製剤
AU2019259686B2 (en) * 2018-04-24 2023-05-25 Shionogi & Co., Ltd. Solid formulation having excellent stability

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3172570D1 (en) * 1981-03-11 1985-11-14 Mirko Beljanski Serpentine, alstonine and sempervirine drugs for the specific inhibition of tumurous and cancerous cells
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
DE3523454A1 (de) * 1985-07-01 1987-01-08 Eberhard Prof Dr Nuernberg Formkoerper
US4925674A (en) * 1988-08-25 1990-05-15 Himedics, Inc. Amoxicillin microencapsulated granules
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
JPH05294839A (ja) * 1992-04-20 1993-11-09 Biomaterial Universe Kk シスプラチン含有生体内分解吸収性高分子の微小球お よびその製造法
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
JPH07112932A (ja) * 1993-08-27 1995-05-02 Mitsui Toatsu Chem Inc 徐放性医薬製剤
JPH0789849A (ja) * 1993-09-20 1995-04-04 Fujisawa Pharmaceut Co Ltd 徐放性製剤
JPH0859460A (ja) * 1994-08-22 1996-03-05 Tanaka Kikinzoku Kogyo Kk 抗ガン剤内包キトサンミクロスフェア及びその製造法
US5637319A (en) * 1995-03-01 1997-06-10 Takada; Kanji Controlled-release preparations
US5614206A (en) * 1995-03-07 1997-03-25 Wright Medical Technology, Inc. Controlled dissolution pellet containing calcium sulfate
AU714992B2 (en) * 1996-08-23 2000-01-13 Alza Corporation Liposomes containing a cisplatin compound

Also Published As

Publication number Publication date
NO993881D0 (no) 1999-08-11
ATE255409T1 (de) 2003-12-15
FR2759293B1 (fr) 1999-04-30
KR100471672B1 (ko) 2005-03-07
US20030017210A1 (en) 2003-01-23
DE69820239D1 (de) 2004-01-15
DE69820239T2 (de) 2004-10-07
US6458389B1 (en) 2002-10-01
JP2001512433A (ja) 2001-08-21
HU225425B1 (en) 2006-11-28
DK0971702T3 (da) 2004-04-13
AU6626798A (en) 1998-08-26
EP0971702B1 (fr) 2003-12-03
IL131326A0 (en) 2001-01-28
EA199900734A1 (ru) 2000-04-24
FR2759293A1 (fr) 1998-08-14
PL335107A1 (en) 2000-04-10
NZ337216A (en) 2000-09-29
AU744001B2 (en) 2002-02-14
BG103647A (en) 2000-03-31
TW561055B (en) 2003-11-11
HUP0001719A2 (hu) 2000-11-28
NO323230B1 (no) 2007-02-05
ZA981123B (en) 1998-08-20
PT971702E (pt) 2004-04-30
IL131326A (en) 2005-03-20
NO993881L (no) 1999-09-29
JP4549445B2 (ja) 2010-09-22
PL191631B1 (pl) 2006-06-30
CA2282082A1 (fr) 1998-08-13
KR20000070997A (ko) 2000-11-25
AR011133A1 (es) 2000-08-02
WO1998034599A1 (fr) 1998-08-13
EA001760B1 (ru) 2001-08-27
BR9807319A (pt) 2000-04-18
EP0971702A1 (fr) 2000-01-19
ES2210726T3 (es) 2004-07-01
BG64247B1 (bg) 2004-07-30
CA2282082C (fr) 2005-10-18
HUP0001719A3 (en) 2005-11-28

Similar Documents

Publication Publication Date Title
BE2018C032I2 (xx)
FR14C0024I1 (xx)
IN187998B (xx)
CH0944937H2 (xx)
IN189871B (xx)
ITMI971063A0 (xx)
IN183034B (xx)
GB9704161D0 (xx)
BE2013C047I2 (xx)
ITFI970037V0 (xx)
ITTO970506A0 (xx)
ITPD970126A0 (xx)
ITMI971278A0 (xx)
ITMI971265A0 (xx)
BR9700653A (xx)
BR9701757A (xx)
CN3059549S (xx)
BY4238C1 (xx)
CN3059396S (xx)
CN3058923S (xx)
CN3055519S (xx)
CN3054556S (xx)
CN3054162S (xx)
CN3055603S (xx)
CN3054099S (xx)